Khalid Shah, MS, PhD: Cell Based Therapies for Cancer: Are We There Yet?


Monday, March 26, 2018, 12:00pm to 1:00pm


Anesthesiology Lecture Hall, L1, Brigham and Women’s Hospital, 45 Francis St, Boston


Khalid Shah

Khalid Shah, MS, PhDDirector, Center for Stem Cell Therapeutics and Imaging  
Vice Chair of Research, Department of Neurosurgery
Brigham and Women’s Hospital 

Associate Professor, Harvard Medical School
Principal Faculty Harvard Stem Cell Institute


Short Bio

Dr. Shah is an Associate Professor at Harvard Medical School and the Director of the Center for Stem Cell Therapeutics and Imaging at BWH. He is also the Vice Chair of Research for the Department of Neurosurgery at BWH and a Principal Faculty at Harvard Stem Cell Institute in Boston. In recent years, Dr. Shah and his team have pioneered major developments in the stem cell therapy field, successfully developing experimental models to understand basic cancer biology and therapeutic stem cells for cancer, particularly brain tumors. These studies have been published in a number of very high impact journals like Nature Neuroscience, PNAS, Nature Reviews Cancer, JNCI, Stem Cells and Lancet Oncology. Recently, Dr. Shah's work has caught the attention in the public domain and as such it has been highlighted in the media world-wide including features on BBC and CNN. Dr. Shah holds current positions on numerous councils, advisory and editorial boards in the fields of stem cell therapy and oncology. In an effort to translate the exciting therapies developed in his laboratory into clinics, he has founded biotech company, AMASA Technologies Inc. whose main objective is the clinical translation of therapeutic stem cells in cancer patients.

See also: Past Seminars